RT Journal Article
SR Electronic
T1 Role of Dopamine D1 and D2 Receptors in the Nucleus Accumbens in Mediating Reward
JF The Journal of Neuroscience
JO J. Neurosci.
FD Society for Neuroscience
SP 8580
OP 8587
DO 10.1523/JNEUROSCI.17-21-08580.1997
VO 17
IS 21
A1 Satoshi Ikemoto
A1 Bradley S. Glazier
A1 James M. Murphy
A1 William J. McBride
YR 1997
UL http://www.jneurosci.org/content/17/21/8580.abstract
AB The objectives of this study were to examine the involvement of D1 and D2 receptors within the nucleus accumbens (ACB) in mediating reinforcement. The intracranial self-administration (ICSA) of D1 and D2agonists was used to determine whether activating D1 and/or D2 receptors within the ACB of Wistar rats is reinforcing. At concentrations of 0.25, 0.50, and 1.0 mm (25, 50, and 100 pmol/100 nl of infusion), neither the D1 agonistR(+)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol [SKF 38393 (SKF)] hydrochloride nor the D2 agonist (−)-quinpirole (Quin) hydrochloride was self-administered into the shell region of the ACB. On the other hand, equimolar mixtures of SKF and Quin (SKF+Quin), at concentrations of 0.25, 0.50, and 1.0 mm each, were significantly self-infused into the ACB shell. The core region of the ACB did not support the ICSA of SKF+Quin at any of these concentrations. Rats increased lever pressing when the response requirement was increased from a fixed ratio 1 (FR1) to FR3, and they responded significantly more on the infusion lever than they did on the control lever. Coadministration of either 0.50 mmR(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 23390) hydrochloride, a D1 antagonist, or 0.50 mmS(−)-sulpiride, a D2antagonist, completely abolished the ICSA of the mixture of SKF+Quin (each at 0.50 mm) into the ACB shell. The present results suggest that concurrent activation of D1- and D2-type receptors in the shell of the ACB had a cooperative effect on DA-mediated reward processes.